In-Vitro Bioequivalence of Paracetamol Tablets available in Syrian Market

Authors

  • Baraa Daghman Tishreen University
  • Hala Barakat Al-Sham Private University
  • Nisrin Kaddar Tishreen University

Abstract

Generic drugs are equivalent in range and absorption to the brand drug. Bioequivalence (BE) test is an essential requirement for interchanging brand and generic drugs, it should be carried out for all generic products, and it is evaluated In Vivo or In Vitro. Because in-vivo studies are expensive and complicated, the concept of In Vitro-In Vivo correlation (IVIVC) has been resorted to. Drugs which achieve (IVIVC) can be evaluated In Vitro only, one of these drugs is Paracetamol. This study aims to carry out BE test of Paracetamol tablets available in Syrian market (500 mg and 1000 mg). Tablets of four local companies A, B, C, D were tested and compared with the brand using dissolution test and calculating similarity and dissimilarity factor (f1 & f2). Other quality control tests were carried out. All tablets achieved weight and content uniformity and showed acceptable friability, with good hardness and a disintegration time of less than 30 minutes. For dissolution test, all tablets released more than 80 % Paracetamol within 30 minutes except A1 and B1 for 500 mg, and B3 for 1000 mg. Similarity and dissimilarity factor were calculated, and one company(C 500 mg) were bioequivalent with brand of the same dose. For 1000 mg tablets, both A and B3 batches showed bioequivalence with the brand.

Downloads

Published

2023-05-18

How to Cite

1.
دغمان ب, هلا بركات, نسرين قدّار. In-Vitro Bioequivalence of Paracetamol Tablets available in Syrian Market. Tuj-hlth [Internet]. 2023May18 [cited 2024Apr.25];45(2):173-91. Available from: https://journal.tishreen.edu.sy/index.php/hlthscnc/article/view/14633

Issue

Vol. 45 No. 2 (2023): Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

Section

Master student researches

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

 Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series   .  The Readers have the right to send, print and subscribe to the initial version of the article, and the title of  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series  Publisher

journal uses a CC BY-NC-SA license which mean

You are free to:

  • Adapt — remix, transform, and build upon the material
  •  
  • The licensor cannot revoke these freedoms as long as you follow the license terms.

 

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.